Search research articles
Contact Us
Filters
Showing results (41-50 of 143) with videos related to
Page
of 15
Sort By:
STAR Protocols
|
November 26, 2021
Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models
Nan Li, Rosa Nguyen, Carol J Thiele, et al.
Pharmacology & Therapeutics
|
May 16, 2021
Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3
Nan Li, Madeline R Spetz, Dan Li, et al.
Proteoglycan Research
|
January 17, 2025
A proteomic atlas of glypican-3 interacting partners: Identification of alpha-fetoprotein and other extracellular proteins as potential immunotherapy targets in liver cancer
Yi-Fan Zhang, Shaoli Lin, Xiao Zhen, et al.
The Journal of Biological Chemistry
|
October 20, 2004
In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxin
Mitchell Ho, Robert J Kreitman, Masanori Onda, et al.
Current Protocols
|
January 3, 2023
Humanization of the Shark V<sub>NAR</sub> Single Domain Antibody Using CDR Grafting
Yi-Fan Zhang, Yaping Sun, Jessica Hong, et al.
Trends in Cancer
|
October 25, 2018
Glypicans as Cancer Therapeutic Targets
Nan Li, Wei Gao, Yi-Fan Zhang, et al.
Antibody Therapeutics
|
December 18, 2019
Highlights of 2019 Protein Engineering Summit (PEGS) in Boston, USA: Advancing Antibody-Based Cancer Therapies to the Clinic
Hong Li, You Li, Cheng Wang, et al.
Seminars in Immunology
|
March 12, 2026
Chimeric antigen receptor therapy for hepatocellular carcinoma
Lorenz Kocheise, Mohamed-Reda Benmebarek, Mitchell Ho, et al.
Oncotarget
|
July 16, 2016
Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy
Chunguang Wang, Wei Gao, Mingqian Feng, et al.
Antibody Therapeutics
|
October 27, 2022
The emergence of AntibodyPlus: the future trend of antibody-based therapeutics
Yong Zhu, Shawn Shouye Wang, Zhaohui Sunny Zhou, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 143) with videos related to
Sort By:
Page
of 15
STAR Protocols
|
November 26, 2021
Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models
Nan Li, Rosa Nguyen, Carol J Thiele, et al.
Pharmacology & Therapeutics
|
May 16, 2021
Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3
Nan Li, Madeline R Spetz, Dan Li, et al.
Proteoglycan Research
|
January 17, 2025
A proteomic atlas of glypican-3 interacting partners: Identification of alpha-fetoprotein and other extracellular proteins as potential immunotherapy targets in liver cancer
Yi-Fan Zhang, Shaoli Lin, Xiao Zhen, et al.
The Journal of Biological Chemistry
|
October 20, 2004
In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxin
Mitchell Ho, Robert J Kreitman, Masanori Onda, et al.
Current Protocols
|
January 3, 2023
Humanization of the Shark V<sub>NAR</sub> Single Domain Antibody Using CDR Grafting
Yi-Fan Zhang, Yaping Sun, Jessica Hong, et al.
Trends in Cancer
|
October 25, 2018
Glypicans as Cancer Therapeutic Targets
Nan Li, Wei Gao, Yi-Fan Zhang, et al.
Antibody Therapeutics
|
December 18, 2019
Highlights of 2019 Protein Engineering Summit (PEGS) in Boston, USA: Advancing Antibody-Based Cancer Therapies to the Clinic
Hong Li, You Li, Cheng Wang, et al.
Seminars in Immunology
|
March 12, 2026
Chimeric antigen receptor therapy for hepatocellular carcinoma
Lorenz Kocheise, Mohamed-Reda Benmebarek, Mitchell Ho, et al.
Oncotarget
|
July 16, 2016
Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy
Chunguang Wang, Wei Gao, Mingqian Feng, et al.
Antibody Therapeutics
|
October 27, 2022
The emergence of AntibodyPlus: the future trend of antibody-based therapeutics
Yong Zhu, Shawn Shouye Wang, Zhaohui Sunny Zhou, et al.
Page
of 15